Please login to the form below

Not currently logged in
Email:
Password:

ADA 2013

This page shows the latest ADA 2013 news and features for those working in and with pharma, biotech and healthcare.

ADA: Boehringer/ Lilly's empagliflozin shows blood glucose benefits

ADA: Boehringer/ Lilly's empagliflozin shows blood glucose benefits

When taken together, the trials, which were presented over the weekend at the American Diabetes Association's (ADA) Scientific Sessions in Chicago, showed “a very consistent efficacy profile of the drug ... in full at next year's ADA meeting.

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...